218 related articles for article (PubMed ID: 15320941)
1. Hemoglobin-based red blood cell substitutes.
Chang TM
Artif Organs; 2004 Sep; 28(9):789-94. PubMed ID: 15320941
[TBL] [Abstract][Full Text] [Related]
2. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.
Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428
[TBL] [Abstract][Full Text] [Related]
3. Oxygen carriers.
Chang TM
Curr Opin Investig Drugs; 2002 Aug; 3(8):1187-90. PubMed ID: 12211412
[TBL] [Abstract][Full Text] [Related]
4. New transfusion strategies: red cell substitutes.
Winslow RM
Annu Rev Med; 1999; 50():337-53. PubMed ID: 10073282
[TBL] [Abstract][Full Text] [Related]
5. Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules.
Chang TM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):418-30. PubMed ID: 20564467
[TBL] [Abstract][Full Text] [Related]
6. Not blood simple.
Stokstad E
Science; 2002 Feb; 295(5557):1003. PubMed ID: 11834812
[No Abstract] [Full Text] [Related]
7. The prospect of hemoglobin-based blood substitutes: Still a long stony road to go.
Bone HG; Westphal M
Crit Care Med; 2005 Mar; 33(3):694-5. PubMed ID: 15753779
[No Abstract] [Full Text] [Related]
8. Future generations of red blood cell substitutes.
Chang TM
J Intern Med; 2003 May; 253(5):527-35. PubMed ID: 12702030
[TBL] [Abstract][Full Text] [Related]
9. Modified hemoglobin-based blood substitutes: crosslinked, recombinant and encapsulated hemoglobin.
Chang TM
Vox Sang; 1998; 74 Suppl 2():233-41. PubMed ID: 9704450
[TBL] [Abstract][Full Text] [Related]
10. Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes.
Patel RP
Free Radic Biol Med; 2000 May; 28(10):1518-25. PubMed ID: 10927176
[TBL] [Abstract][Full Text] [Related]
11. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
Bian Y; Rong Z; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2011 Jun; 39(3):127-36. PubMed ID: 21574914
[TBL] [Abstract][Full Text] [Related]
12. Nanobiotechnology for hemoglobin-based blood substitutes.
Chang TM
Crit Care Clin; 2009 Apr; 25(2):373-82, Table of Contents. PubMed ID: 19341914
[TBL] [Abstract][Full Text] [Related]
13. Polymer/hemoglobin assemblies: biodegradable oxygen carriers for artificial red blood cells.
Li T; Jing X; Huang Y
Macromol Biosci; 2011 Jul; 11(7):865-75. PubMed ID: 21312333
[TBL] [Abstract][Full Text] [Related]
14. Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.
Chang TM
Biochim Biophys Acta; 2008 Oct; 1784(10):1435-40. PubMed ID: 18565337
[TBL] [Abstract][Full Text] [Related]
15. Red cell substitutes from hemoglobin--do we start all over again?
Kluger R
Curr Opin Chem Biol; 2010 Aug; 14(4):538-43. PubMed ID: 20392662
[TBL] [Abstract][Full Text] [Related]
16. Basic science offers a challenge for developing hemoglobin based oxygen carriers into therapeutic agents.
Bucci E
Artif Cells Blood Substit Immobil Biotechnol; 2011 Aug; 39(4):206-13. PubMed ID: 21692690
[TBL] [Abstract][Full Text] [Related]
17. Blood substitutes: the future is now.
Moore EE
J Am Coll Surg; 2003 Jan; 196(1):1-17. PubMed ID: 12517544
[No Abstract] [Full Text] [Related]
18. Artificial O2 carriers: status in 2005.
Spahn DR; Kocian R
Curr Pharm Des; 2005; 11(31):4099-114. PubMed ID: 16378514
[TBL] [Abstract][Full Text] [Related]
19. Future prospects for artificial blood.
Chang TM
Trends Biotechnol; 1999 Feb; 17(2):61-7. PubMed ID: 10087605
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of hemoglobin therapeutics.
Gulati A; Barve A; Sen AP
J Lab Clin Med; 1999 Feb; 133(2):112-9. PubMed ID: 9989762
[No Abstract] [Full Text] [Related]
[Next] [New Search]
